Networked Scanners
PRODUCTS
-
Niche CRO with a difference
Worldwide Oncology is a niche oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our passion because every second counts for patients with cancer and their families.
-
Companies are under constant pressure to accelerate drug development while managing tight budgets and headcount restrictions. Many turn to temporary staffing, but this model often falls short for long-term needs.
-
The revolutionary ThermAer Process achieves the results you want without compromising quality or cost objectives.
-
The IADA-2050CH is an integrated MMIC active doubler fabricated with GaAs Schottky diodes. This operates over a guaranteed 10 to 25 GHz input frequency range or a doubled output frequency range of 20 to 50 GHz.
-
120Water creates an easy, resident-friendly experience that takes the hassle out of compliance sampling for you. From easy-to-use kits and comprehensive collection support, to data collection and reporting, our team can lighten the load of your next monitoring period.
WHITE PAPERS AND CASE STUDIES
-
Formulation Development Of Enterically Protected Spray Dried Dispersions
Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.
-
Alerion Microbubble Cell Separation System Used For T Cell Negative Selection
Discover how the Alerion™ Microbubble Cell Separation System outperformed standard magnetic methods in T cell recovery, speed, and scalability — achieving higher cell quality with Akadeum’s innovative microbubble technology.
-
Tailored Approach Supports Bladder Cancer Breakthrough
Discover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.
-
Simplify CAPA In 7 Steps
Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.
-
Expand Bandwidth With A Trusted Regulatory Writing Partner
Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.
-
Life Sciences Corporation Implements eLogbooks Across 15 Sites
New regulations challenged how surgical kits were tracked and processed across 15 U.S. sites. Discover how one team balanced compliance and efficiency to keep life-saving procedures on schedule.
-
Collaborative Variability Reduction In Cell Culture Media
Variability reduction programs improve biomanufacturing by controlling raw‑material complexity, optimizing critical attributes, and boosting productivity through data‑driven partnerships.
-
Disinfection For Purified Water Loop For Kamada Pharmaceuticals, Israel
An Atlantium HOD™ (Hydro-Optic Disinfection) UV system was installed at the outlet of a PW tank to serve as the primary disinfection barrier, with water circulating through the system at 6m³/hr before reaching the points of use.
-
Bringing Clinical Testing To New Heights In New Jersey
Explore how clinical testing was transformed with a pioneering BSL-2 mobile laboratory on a Sprinter Van platform to enhance safety and portability for advanced biosafety requirements.
-
Restarting A Manufacturing Campus And Revitalizing A Community
A high‑risk facility acquisition in Huntsville became a blueprint for revitalizing a modern pharmaceutical campus. Discover how coordinated action turned a massive shutdown into a renewed manufacturing hub.
-
Low Capacitance SWIR Photodetectors For High Speed Sensing Applications
Sensors Unlimited Inc. developed high-speed SWIR focal plane arrays with reduced capacitance for improved LiDAR performance, enhancing laser pulse detection, low-light imaging, and laser range-finding applications.
-
Development And Optimization Of Suspension-Adapted 293T Cell Line
Learn how an adapted cell line can reduce costs and improve scalability in the production of lentiviral vectors for CGTs and examine its potential to produce GMP-grade lentiviral vectors.
NEWS
-
Novotech Named Best Contract Research Organization In Australia At Asia-Pacific Biopharma Excellence Awards 20254/3/2025
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market has been recognized as the Best Contract Research Organization in Australia at the Asia-Pacific Biopharma Excellence Awards (ABEA) 2025.
-
ProBioGen And Zag Bio Forge Strategic CMC Partnership To Advance Fc-Fusion Autoimmune Therapy1/6/2026
ProBioGen announced today the signing of a Master Service Agreement ("MSA") with Zag Bio, Inc., a biotechnology company developing thymus-targeted therapies to induce central immune tolerance.
-
SGD Pharma Leads Pharma Packaging Innovation And Decarbonization At PharmaPack Europe 20261/28/2026
SGD Pharma, a global market leader in pharmaceutical glass primary packaging and the leader of its industry on sustainability, will showcase its latest advancements in high-performance solutions at Pharmapack Europe, taking place in Paris on 21st to 22nd January 2026.
-
ProBioGen Enters Agreement With Polpharma Biologics To Provide High-Performance Cell Line Development Services5/7/2025
ProBioGen announced today an agreement with Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars. Under this agreement ProBioGen will conduct high-performance cell line development services for Polpharma's biosimilar candidate, supporting their expanding pipeline.
-
ArriVent BioPharma Enters Exclusive License With Lepu Biopharma For MRG007, An Antibody Drug Conjugate For The Treatment Of Gastrointestinal Cancers1/21/2025
ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP) a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it has entered into an exclusive license agreement with Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) for MRG007, an antibody-drug conjugate (ADC) that can target several gastrointestinal (GI) cancers.